DOSSIER · 13F Holders · Q3 2026

TEVA PHARMACEUTICAL-SP ADR

379 institutions still hold TEVA PHARMACEUTICAL-SP ADR as of Q3 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.

CUSIP M8769Q102·379 13F holders·last filed Sep 30, 2026
Market cap
—
13F value held
$15.2B
visible holders
Holders
379
filers reporting
Concentration
29.78%
BANK OF MONTREAL /CAN/ #1
top holder share
AI Holders Summary · Q3 2026

379 institutions reported TEVA PHARMACEUTICAL-SP ADR in Q3 2026. BANK OF MONTREAL /CAN/ leads at 29.8% of the visible book.

Top holders

Sorted by position value. Source: SEC EDGAR 13F-HR filings.

#HolderValueShares% port.Quarter
01
BANK OF MONTREAL /CAN/
CIK 0000927971
$4.5B1.1M1.45%Q3 2026
02
Phoenix Financial Ltd.
CIK 0001679543
$1.7B42.6M11.38%Q3 2026
03
WCM INVESTMENT MANAGEMENT, LLC
CIK 0001061186
$1.7B42.3M2.85%Q3 2026
04
Harel Insurance Investments & Financial Services Ltd.
CIK 0001429390
$1.4B34.7M6.45%Q3 2026
05
FMR LLC
CIK 0000315066
$1.0B25.8M0.04%Q3 2026
06
STATE STREET CORP
CIK 0000093751
$765M19.3M0.02%Q3 2026
07
Capital World Investors
CIK 0001422849
$713M18.0M0.09%Q3 2026
08
Lingotto Investment Management LLP
CIK 0001732768
$694M17.5M12.10%Q3 2026
09
GEODE CAPITAL MANAGEMENT, LLC
CIK 0001214717· Index
$470M11.9M0.02%Q3 2026
10
JPMORGAN CHASE & CO
CIK 0000019617
$370M9.3M0.02%Q3 2026
11
Y.D. More Investments Ltd
CIK 0001870364
$277M6.9M7.99%Q3 2026
12
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC
CIK 0001644956
$242M6.1M0.79%Q3 2026
13
Evelyn Partners Group Ltd
CIK 0002146944
$234M4803.74%Q3 2026
14
BESSEMER GROUP INC
CIK 0001054074
$211M5.3M0.29%Q3 2026
15
Invesco Ltd.
CIK 0000914208
$200M5.0M0.02%Q3 2026
16
Swiss National Bank
CIK 0001582202
$163M4.1M0.09%Q3 2026
17
DEUTSCHE BANK AG\
CIK 0000948046
$149M3.8M0.04%Q3 2026
18
SOUND SHORE MANAGEMENT INC /CT/
CIK 0000820124
$145M3.7M4.55%Q3 2026
19
FIL Ltd
CIK 0000318989
$142M3.6M0.10%Q3 2026
20
JANE STREET GROUP, LLC
CIK 0001595888· Market maker
$140M3.5M0.01%Q3 2026
Page 1 of 19
359 more holders available. Log in →